Teva Canada

Teva Canada, established in 1965 and headquartered in Toronto, Ontario, is a significant player in the Canadian pharmaceutical sector. Operating within the Healthcare and Pharmaceuticals industries, the company focuses on the manufacturing and distribution of generic, biosimilar, and specialty medications. With a history spanning over five decades, Teva Canada has built a reputation for providing high-quality healthcare solutions across various therapeutic areas. Its product portfolio encompasses a wide range of prescription pharmaceuticals designed to meet diverse patient needs, contributing to accessible healthcare options nationwide.

The company operates across 6 locations, employing between 1,000 and 5,000 individuals. This substantial workforce supports its extensive operations and commitment to innovation in pharmaceutical development and manufacturing. Teva Canada's presence in Toronto, Ontario, serves as a key hub for its Canadian activities. For insights into the people driving its mission, consider Meet Teva Canada's team. The company's operational footprint and dedication to quality are central to its market strategy.

With an annual revenue of $319.8M, Teva Canada competes in a dynamic market against entities such as Lundbeck, BioScript Solutions, and Medical Pharmacies Group. Its strategic focus on generic and specialty pharmaceuticals positions it to address evolving healthcare demands and maintain a competitive edge. The company's URL, www.tevacanada.com, provides further information on its offerings and corporate initiatives.